Form 4 for INSM INSMED Inc
Accepted 2021-10-01 00:00:00 ET · period of report 2021-09-30 · accession 0001140361-21-033275 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-10-01 | 2021-09-30 | INSM | Lewis William | COB, CEO, Dir | M - OptEx | $3.40 | +96.6K | 298.8K | +48% | +$328.5K |
| DM | 2021-10-01 | 2021-09-30 | INSM | Lewis William | COB, CEO, Dir | S - Sale+OE | $27.36 | -96.6K | 202.2K | -32% | -$2.64M |
| D | 2021-10-01 | 2021-09-30 | INSM | Lewis William | COB, CEO, Dir | M - OptEx | $0.00 | -96.6K | 3,386 | -97% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-30 | M | A | 96,614 | $3.40 | 298,833 | D | — | — | (F2) Includes 748 shares acquired through the Company's 2018 Employee Stock Purchase Plan. |
| 2 | Common | Common Stock | 2021-09-30 | S | D | 83,307 | $27.32 | 215,526 | D | — | — | (F3) This is the weighted average sales price representing 83,307 shares sold at prices ranging from $26.60 to $27.59 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 3 | Common | Common Stock | 2021-09-30 | S | D | 13,307 | $27.64 | 202,219 | D | — | — | (F4) This is the weighted average sales price representing 13,307 shares sold at prices ranging from $27.60 to $27.74 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 4 | Derivative | Stock Option (right to buy) | 2021-09-30 | M | D | 96,614 | $0.00 | 3,386 | D | $3.40 · — to 2022-09-10 | 96,614 Common Stock | (F5) The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. |